Table 4.

Effect of carveol at different doses and metformin on glycosylated hemoglobin A1C (HbA1C) in alloxan-induced diabetic rats.

Group	HbA1c level (%)
Non-Diabetic Control (Saline, 10 mL/Kg)	5.0 ± 0.05
Diabetic Control (Alloxan 1055.8 µMol/Kg)	7.1 ± 0.11###
Alloxan (1055.8 µMol/Kg) + Carveol (65.7 µMol/Kg)	5.6 ± 0.14***
Alloxan (1055.8 µMol/Kg) + Carveol (197 µMol/Kg)	5.2 ± 0.11***
Alloxan (1055.8 µMol/Kg) + Carveol (394.1µMol/Kg)	4.9 ± 0.06***
Alloxan (1055.8 µMol/Kg) + Metformin (1207.5 µMol/Kg)	5.1 ± 0.10***

Values expressed as mean ± SEM. One-way ANOVA was used for statistical analysis, followed by post-hoc Dunnett test. ^###p < 0.001 vs. saline group, and ^***p < 0.001 comparison of the HbA1C levels of carveol- and metformin-treated groups vs. diabetic control group.